Biogen Idec (BIIB)

Add to Watchlists
Create an Alert
321.67 +5.61  +1.77% NASDAQ Oct 24, 8:00PM BATS Real time Currency in USD
View Full Chart
BIIB Price Chart
View All Events

BIIB Events

Date Type Description
10/22/2014 09:00 EDT Misc Q3 2014 Biogen Idec Inc. Earnings Conference Call
10/22/2014 Earnings Q3 2014 Biogen Idec Inc. Earnings Results
07/23/2014 09:00 EDT Misc Q2 2014 Biogen Idec Inc Earnings Conference Call
07/23/2014 Earnings Q2 2014 Biogen Idec Inc Earnings Results
06/12/2014 Misc Annual General Meeting for Biogen Idec Inc
04/23/2014 08:00 EDT Misc Biogen Idec Inc Q1 2014 Earning Conference Call
04/23/2014 Earnings Biogen Idec Inc Q1 2014 Earning Result
01/29/2014 08:00 EDT Misc Biogen Idec to Report Fourth Quarter and Year-end 2013 Financial Results on January 29, 2014
01/29/2014 Earnings Biogen Idec to Report Fourth Quarter and Year-end 2013 Financial Results
10/28/2013 09:00 EDT Misc Iogen Idec to Report Third Quarter 2013 Financial Results Conference Call
View All Performance Charts

BIIB Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biogen Idec is up 29.07% over the last year vs S&P 500 Total Return up 14.46%, Gilead Sciences up 58.54%, and Celgene up 30.72%.

Get Quote for

PDF Report for BIIB

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BIIB Pro Report PDF
Advertisement

Portfolio Strategies Featuring BIIB

Did Biogen Idec make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BIIB Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.biogenidec.com
  • IR Website: http://www.biogenidec.com/investors.aspx?ID=5494
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Biogen Idec Inc, is a biotechnology company that discovers, develops, manufactures and markets therapies for the treatment of multiple sclerosis (MS) and other autoimmune disorders, neurodegenerative diseases and hemophilia.

BIIB Excel Add-In Codes

  • Name: =YCI("BIIB","name")
  • Description: =YCI("BIIB","description")
  • Sector: =YCI("BIIB","sector")
  • Industry: =YCI("BIIB","industry")
  • Est. Current Fiscal Year End: =YCI("BIIB","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.